Synopsis
Synopsis
0
EU WC
0
VMF
0
Australia
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Molecular Weight | 397.4 g/mol |
---|---|
Molecular Formula | C18H24NO7P |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 1 |
Exact Mass | 397.12903910 g/mol |
Monoisotopic Mass | 397.12903910 g/mol |
Topological Polar Surface Area | 120 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 558 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 5 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Certificate Number : CEP 1997-118 - Rev 12
Issue Date : 2024-03-01
Type : Chemical
Substance Number : 74
Status : Valid
Registrant Name : Nosa Chemical Co., Ltd.
Registration Date : 2020-06-16
Registration Number : 20200616-209-J-616
Manufacturer Name : Saneca Pharmaceuticals as
Manufacturer Address : Nitrianska 100, 920 27 Hlohovec, Slovak Republic
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20787
Submission : 2007-08-23
Status : Active
Type : II
Certificate Number : R1-CEP 2016-295 - Rev 00
Issue Date : 2022-10-06
Type : Chemical
Substance Number : 74
Status : Valid
Registrant Name : Samung Industrial Co., Ltd.
Registration Date : 2021-03-16
Registration Number : 20210316-209-J-603
Manufacturer Name : Macfarlan Smith Limited@Macfarlan Smith Limited@Tasmanian Alkaloids Pty Limited
Manufacturer Address : Three Trees Road Newbie, Annan DG12 5QH United Kingdom@10 Wheatfield Road, Edinburgh, EH11 2QA, United Kingdom@160 Birralee Road, Westbury, Tasmania, 7303, Australia
Certificate Number : CEP 2021-385 - Rev 01
Issue Date : 2024-02-06
Type : Chemical
Substance Number : 74
Status : Valid
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-05-16
Pay. Date : 2012-11-23
DMF Number : 25856
Submission : 2012-03-30
Status : Active
Type : II
NDC Package Code : 51634-0999
Start Marketing Date : 1986-06-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Certificate Number : R1-CEP 1999-053 - Rev 03
Issue Date : 2014-12-19
Type : Chemical
Substance Number : 74
Status : Valid
Registrant Name : Baeksu Pharmaceutical Co., Ltd.
Registration Date : 2021-03-16
Registration Number : 20210316-209-J-603(1)
Manufacturer Name : Macfarlan Smith Limited@Macfarlan Smith Limited@Tasmanian Alkaloids Pty Limited
Manufacturer Address : Three Trees Road, Newbie, Annan Dumfriesshire, DG12 5QH, United Kingdom@10 Wheatfield Road, Edinburgh, EH11 2QA, United Kingdom@160 Birralee Road, Westbury, Tasmania, 7303, Australia
Certificate Number : R1-CEP 2010-052 - Rev 01
Issue Date : 2019-01-18
Type : Chemical
Substance Number : 74
Status : Valid
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-05-05
Pay. Date : 2012-12-27
DMF Number : 20213
Submission : 2007-01-29
Status : Active
Type : II
NDC Package Code : 0792-0644
Start Marketing Date : 2007-01-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
37
PharmaCompass offers a list of Codeine Phosphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Codeine Phosphate manufacturer or Codeine Phosphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Codeine Phosphate manufacturer or Codeine Phosphate supplier.
PharmaCompass also assists you with knowing the Codeine Phosphate API Price utilized in the formulation of products. Codeine Phosphate API Price is not always fixed or binding as the Codeine Phosphate Price is obtained through a variety of data sources. The Codeine Phosphate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A TRIACIN-C manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of TRIACIN-C, including repackagers and relabelers. The FDA regulates TRIACIN-C manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. TRIACIN-C API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of TRIACIN-C manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A TRIACIN-C supplier is an individual or a company that provides TRIACIN-C active pharmaceutical ingredient (API) or TRIACIN-C finished formulations upon request. The TRIACIN-C suppliers may include TRIACIN-C API manufacturers, exporters, distributors and traders.
click here to find a list of TRIACIN-C suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A TRIACIN-C DMF (Drug Master File) is a document detailing the whole manufacturing process of TRIACIN-C active pharmaceutical ingredient (API) in detail. Different forms of TRIACIN-C DMFs exist exist since differing nations have different regulations, such as TRIACIN-C USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A TRIACIN-C DMF submitted to regulatory agencies in the US is known as a USDMF. TRIACIN-C USDMF includes data on TRIACIN-C's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The TRIACIN-C USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of TRIACIN-C suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The TRIACIN-C Drug Master File in Japan (TRIACIN-C JDMF) empowers TRIACIN-C API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the TRIACIN-C JDMF during the approval evaluation for pharmaceutical products. At the time of TRIACIN-C JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of TRIACIN-C suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a TRIACIN-C Drug Master File in Korea (TRIACIN-C KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of TRIACIN-C. The MFDS reviews the TRIACIN-C KDMF as part of the drug registration process and uses the information provided in the TRIACIN-C KDMF to evaluate the safety and efficacy of the drug.
After submitting a TRIACIN-C KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their TRIACIN-C API can apply through the Korea Drug Master File (KDMF).
click here to find a list of TRIACIN-C suppliers with KDMF on PharmaCompass.
A TRIACIN-C CEP of the European Pharmacopoeia monograph is often referred to as a TRIACIN-C Certificate of Suitability (COS). The purpose of a TRIACIN-C CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of TRIACIN-C EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of TRIACIN-C to their clients by showing that a TRIACIN-C CEP has been issued for it. The manufacturer submits a TRIACIN-C CEP (COS) as part of the market authorization procedure, and it takes on the role of a TRIACIN-C CEP holder for the record. Additionally, the data presented in the TRIACIN-C CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the TRIACIN-C DMF.
A TRIACIN-C CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. TRIACIN-C CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of TRIACIN-C suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing TRIACIN-C as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for TRIACIN-C API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture TRIACIN-C as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain TRIACIN-C and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a TRIACIN-C NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of TRIACIN-C suppliers with NDC on PharmaCompass.
TRIACIN-C Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of TRIACIN-C GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right TRIACIN-C GMP manufacturer or TRIACIN-C GMP API supplier for your needs.
A TRIACIN-C CoA (Certificate of Analysis) is a formal document that attests to TRIACIN-C's compliance with TRIACIN-C specifications and serves as a tool for batch-level quality control.
TRIACIN-C CoA mostly includes findings from lab analyses of a specific batch. For each TRIACIN-C CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
TRIACIN-C may be tested according to a variety of international standards, such as European Pharmacopoeia (TRIACIN-C EP), TRIACIN-C JP (Japanese Pharmacopeia) and the US Pharmacopoeia (TRIACIN-C USP).